Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Lifecore Biomedical, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 75 | 1 | 82 | +8 |
| Shares | 20.4M | 1.45M | 20.7M | +1.79M (+9.5%) |
| Value | $119.4M | $7.45M | $117.0M | +$5.04M (+4.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Lifecore Biomedical, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,512,946 | $7.46M | 0.00% |
| Jacobs Levy Equity Management, Inc | 42,074 | $207.4K | 0.00% |
| ExodusPoint Capital Management, LP | 41,529 | $205.0K | 0.00% |
| Squarepoint Ops LLC | 27,774 | $136.9K | 0.00% |
| Prelude Capital Management, LLC | 27,504 | $135.6K | 0.01% |
| Public Employees Retirement System of Ohio | 24,153 | $119.1K | 0.00% |
| Shay Capital LLC | 23,000 | $113.4K | 0.03% |
| Jump Financial, LLC | 22,147 | $109.2K | 0.00% |
| Creative Planning | 14,000 | $69.0K | 0.00% |
| Cresset Asset Management, LLC | 12,848 | $63.3K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 11,690 | $57.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,261 | $11.1K | 0.00% |
| Fifth Third Bancorp | 220 | $1.08K | 0.00% |
| Lazard Asset Management LLC | 277 | $1.00K | 0.00% |
| GAMMA Investing LLC | 154 | $759 | 0.00% |
| Russell Investments Group, Ltd. | 84 | $414 | 0.00% |
| Sterling Capital Management LLC | 68 | $335 | 0.00% |
| Allspring Global Investments Holdings, LLC | 64 | $315 | 0.00% |
| Capital Performance Advisors LLP | 2 | $10 | 0.00% |
Sold out (11)
Institutions that held Lifecore Biomedical, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Visionary Wealth Advisors | 491,013 | $2.52M |
| Citadel Advisors LLC | 42,437 | $217.7K |
| Laurion Capital Management LP | 38,773 | $198.9K |
| Man Group plc | 38,714 | $198.6K |
| Alpine Global Management, LLC | 20,904 | $107.2K |
| Boston Partners | 14,212 | $72.9K |
| Bank of Montreal | 12,165 | $64.8K |
| Cutter & CO Brokerage, Inc. | 12,334 | $63.3K |
| Corton Capital Inc. | 12,118 | $62.2K |
| Renaissance Technologies LLC | 11,000 | $56.4K |
| Parallel Advisors, LLC | 225 | $1.15K |
Not filed for Q3 2024 yet (1)
Institutions that held Lifecore Biomedical, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,452,634 | $7.45M |